CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Autor: Guido Gini, Alice Di Rocco, Luca Nassi, Annalisa Arcari, Maria Chiara Tisi, Giacomo Loseto, Attilio Olivieri, Massimo Gentile, Ombretta Annibali, Maria Giuseppina Cabras, Annalisa Chiappella, Chiara Rusconi, Andrés José María Ferreri, Monica Balzarotti

Publikováno v: Frontiers in Oncology, Vol 11 (2021)

Externí odkaz: https://doaj.org/article/22196f7f9b634ea4b5a861b916e80c36

The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study

Autor: Luigi Barberini, Antonio Noto, Claudia Fattuoni, Giannina Satta, Mariagrazia Zucca, Maria Giuseppina Cabras, Ester Mura, Pierluigi Cocco

Publikováno v: Molecules, Vol 24, Iss 13, p 2367 (2019)

Lymphoma defines a group of different diseases. This study examined pre-treatment plasma samples from 66 adult patients (aged 20−74) newly diagnosed with any lymphoma subtype, and 96 frequency matched population controls. We used gas chromatography

Externí odkaz: https://doaj.org/article/ebf4827de20c4ea7a111c676da990fd5

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Autor: Andrés J M, Ferreri, Kate, Cwynarski, Elisa, Pulczynski, Christopher P, Fox, Elisabeth, Schorb, Claudia, Celico, Monica, Falautano, Alessandro, Nonis, Paul, La Rosée, Mascia, Binder, Alberto, Fabbri, Fiorella, Ilariucci, Mauro, Krampera, Alexander, Roth, Claire, Hemmaway, Peter W, Johnson, Kim M, Linton, Tobias, Pukrop, Jettes Sønderskov, Gørløv, Monica, Balzarotti, Georg, Hess, Ulrich, Keller, Stephan, Stilgenbauer, Jense, Panse, Alessandra, Tucci, Lorella, Orsucci, Francesco, Pisani, Manuela, Zanni, Stefan W, Krause, Hans J, Schmoll, Bernd, Hertenstein, Mathias, Rummel, Jeffery, Smith, Lorenz, Thurner, Giuseppina, Cabras, Elsa, Pennese, Maurilio, Ponzoni, Martina, Deckert, Letterio S, Politi, Jurgen, Finke, Antonella, Ferranti, Kelly, Cozens, Elvira, Burger, Nicoletta, Ielmini, Franco, Cavalli, Emanuele, Zucca, Gerald, Illerhaus

Publikováno v: Ferreri, A J M, Cwynarski, K, Pulczynski, E, Fox, C P, Schorb, E, Celico, C, Falautano, M, Nonis, A, La Rosée, P, Binder, M, Fabbri, A, Ilariucci, F, Krampera, M, Roth, A, Hemmaway, C, Johnson, P W, Linton, K M, Pukrop, T, Gørløv, J S, Balzarotti, M, Hess, G, Keller, U, Stilgenbauer, S, Panse, J, Tucci, A, Orsucci, L, Pisani, F, Zanni, M, Krause, S W, Schmoll, H J, Hertenstein, B, Rummel, M, Smith, J, Thurner, L, Cabras, G, Pennese, E, Ponzoni, M, Deckert, M, Politi, L S, Finke, J, Ferranti, A, Cozens, K, Burger, E, Ielmini, N, Cavalli, F, Zucca, E, Illerhaus, G & IELSG32 study investigators 2022, ' Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma : 7-year results of the IELSG32 randomized trial ', Leukemia, vol. 36, no. 7, pp. 1870-1878 . https://doi.org/10.1038/s41375-022-01582-5

219 HIV-negative adults ≤70 years with primary CNS lymphoma (PCNSL) were enrolled in the randomized IELSG32 trial. Enrolled patients were randomly assigned to receive methotrexate-cytarabine (arm A), or methotrexate-cytarabine-rituximab (B), or met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca71e062cac7ea0aa1bd288b51b3ad3b
https://pubmed.ncbi.nlm.nih.gov/35562406

PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)

Autor: Emanuele Zucca, Monica Tani, Guido Gini, Annarita Conconi, Roch Houot, O. Casasnovas, Alessandro Pulsoni, Michele Spina, Francesco Merli, Luca Baldini, Remy Gressin, Catherine Thieblemont, Maria Giuseppina Cabras, B. De Renzis, Manuela Zanni, Guillaume Cartron, F. Esposito, U. Occhini, Corinne Haioun, Dario Marino, F. Palombi, Hervé Ghesquières, Annalia Molinari, Hervé Tilly, Federica Cavallo, Liliana Devizzi, Lorella Orsucci, F. Morschhauser, S. Le Gouill, E. Gyan, Michele Merli, Davide Rossi, Francesco Angrilli, Stefano Luminari, Giuseppe Pietrantuono, Maria Cristina Pirosa, Anastasios Stathis, N. Ielmini, Francesco Bertoni, Franco Cavalli, Gerardo Musuraca, Francesca Re, P. Feugier, Enrico Capochiani, Anna Marina Liberati, Catello Califano

Publikováno v: Hematological Oncology. 39

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a0dc7b5dc1d1dda8de18ffd84769c73
https://doi.org/10.1002/hon.79_2879

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

Autor: Wendy Osborne, Kelly Cozens, Elisabetta Gastaldi, Urban Novak, Vikram Singh, Claudia Cellini, Mario Luppi, Jeanette K. Doorduijn, Francesca Re, Christopher P. Fox, Jeffery Smith, Anna Marina Liberati, Andrew Davies, Emanuele Zucca, Maurizio Frezzato, Kate Cwynarski, Alessandro Fanni, Jacopo Olivieri, Andrés J.M. Ferreri, Kim Linton, Fiorella Ilariucci, Jahanzaib Khwaja, Alessandro Re, Jacoline E C Bromberg, Nicola Cascavilla, Pam McKay, Renato Zambello, Massimo Bernardi, Maria Giuseppina Cabras, Caterina Patti, Chiara Cattaneo, Barbara Botto, Luca Nassi, Teresa Calimeri

Publikováno v: The Lancet Haematology, 8(2), e110-e121. Lancet Publishing Group
International Extranodal Lymphoma Study Group (IELSG) 2021, ' MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA) : an international, single-arm, phase 2 trial ', The Lancet. Haematology, vol. 8, no. 2, pp. e110-e121 . https://doi.org/10.1016/S2352-3026(20)30366-5
The Lancet. Haematology
Ferreri, Andrés J M; Doorduijn, Jeanette K; Re, Alessandro; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Luppi, Mario; Calimeri, Teresa; Cattaneo, Chiara; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2021). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. The Lancet. Haematology, 8(2), e110-e121. Elsevier 10.1016/S2352-3026(20)30366-5

Background: Secondary CNS lymphoma is a rare but potentially lethal event in patients with diffuse large B-cell lymphoma. We aimed to assess the activity and safety of an intensive, CNS-directed chemoimmunotherapy consolidated by autologous haematopo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0229c2b8052c92ea24b616224b1242b